The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance

Journal of Pharmaceutical Sciences

Volumn 96, Issue 5, 2007, Pages 1331-1341

  Young, Paul M ^a   Chan, Hak Kim ^a   Chiou, Herbert ^a   Edge, Stephen ^a   Tee, Terence H S ^a   Traini, Daniela ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Aerosolization; Amorphous; Dry powder; Fines; Inhalation; Milling; Recrystallization; Surface activation

Indexed keywords

ALPHA LACTOSE; DRUG CARRIER; NEDOCROMIL SODIUM;

AEROSOL; ANALYSIS OF VARIANCE; ARTICLE; CORRELATION ANALYSIS; CRYSTALLIZATION; DRUG FORMULATION; DRY POWDER; HUMIDITY; IN VITRO STUDY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY;

EID: 34249281670     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20933     Document Type: Article

References (33)

1. Edge S, Kibbe A, Kussendrager K. 2006. Lactose, Monohydrate. In: Rowe RC, Sheskey PJ, Owen SC, editors. Handbook of pharmaceutical excipients, 5th Edition. London: Pharmaceutical Press. pp 389-395.
2. Steckel H, Markefka P, teWierik H, Kammelar R. 2004. Functionality testing of inhalation grade lactose. Eur J Pharm Biopharm 57:495-505.
3. Bell JH, Hartley PS, Cox JS. 1971. Dry powder aerosols. I. A new powder inhalation device. J Pharm Sci 60:1559-1564.
4. French DL, Edwards DA, Niven RW. 1996. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J Aerosol Sci 27:769-783.
5. Steckel H, Müller BW. 1997. In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition. Int J Pharm 154:31-37.
6. Zeng XM, Martin GP, Tee SK, Ghoush AA, Marriott C. 1999. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation. Int J Pharm 182:133-144.
7. Islam N, Stewart P, Larson I, Hartley P. 2004. Effect of carrier size on the dispersion of salmeterol xinaofoate from interactive mixtures. J Pharm Sci 93:1030-1038.
8. Lucas P, Anderson K, Stanniforth JN. 1998. Protein deposition from dry powder inhalers: Fine particle multiplets as performance modifiers. Pharm Res 15:562.
9. Zeng XM, Martin GP, Tee SK, Marriott C. 1998. The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro. Int J Pharm 176:99-110.
10. Louey MD, Stewart PJ. 2002. Particle interactions involved in aerosol dispersion of ternary interactive mixtures. Pharm Res 19:1524-1531.
11. Louey MD, Razia S, Stewart PJ. 2003. Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int J Pharm 252:87-98.
12. Islam N, Stewart P, Larson I, Hartley P. 2004. Lactose surface modification by decantation: Are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? Pharm Res 21:492-499.
13. Steckel H, Markefka P, teWierik H, Kammelar R. 2006. Effect of milling and sieving on functionality of dry powder inhalation products. Int J Pharm 309:51-59.
14. Zeng XM, Martin GP, Marriott C, Pritchard J. 2000. The influence of carrier morphology on drug delivery by dry powder inhalers. Int J Pharm 200: 93-106.
15. Flament MP, Leterme P, Gayot A. 2004. The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers. Int J Pharm 275:201-209.
16. Young PM, Cocconi D, Colombo P, Bettini R, Price R, Steele DF, Tobyn MJ. 2002. Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing". J Pharm Pharmacol 54:1339-1344.
17. Price R, Young PM. 2005. On the physical transformations of processed pharmaceutical solids. Micron 36:519-524.
18. Buckton G, Darcy P. 1999. Assessment of disorder in crystalline powders - a review of analytical techniques and their application. Int J Pharm 179:141-158.
19. Young PM, Price R. 2004. The influence of humidity on the aerolisation of micronised and SEDS produced salbutamol sulphate. Eur J Pharm Sci 22:235-240.
20. Podczeck F, Newton JM, James MB. 1997. Variations in the adhesion force between a drug and carrier particles as a result of changes in the relative humidity of the air. Int J Pharm 149:151-160.
21. Ward GH, Schultz RK. 1995. Processed-induced crystallinity changes in albuterol sulphate and its effect on powder physical stability. Pharm Res 12:773-779.
22. Young PM, Chiou H, Tee T, Traini D, Chan HK, Thielmann F, Burnett D. 2007. The use of organic vapor sorption to determine low levels of amorphous content in processed pharmaceutical powders. Drug Dev Ind Pharm 33:91-97.
23. Chen Y, Ding Y, Papadopoulos DG, Ghadiri M. 2004. Energy-based analysis of milling alpha-lactose monohydrate. J Pharm Sci 93:886-895.
24. Kwan CC, Chen YQ, Ding YL, Papadopoulos DG, Bentham AC, Ghadiri M. 2004. Development of a novel approach towards predicting the milling behaviour of pharmaceutical powders. Eur J Pharm Sci 23:327-336.
25. Berg TGO, Avis LE. 1970. Exploratory experiments on kinetics of comminution. Powder Technol 4:27-31.
26. Piret EL. 1953. Fundamental aspects of grinding. Chem Eng Prog 49:56-62.
27. Parrott EL. 1974. Milling of pharmaceutical solids. [Review] [95 refs]. J Pharm Sci 63:813-829.
28. Coelho MC, Harnby N. 1978. Moisture bonding in powders. Powder Technol 2:201-205.
29. Schubert H. 1984. Capillary forces: Modelling and application in particulate technology. Powder Technol 37:105-116.
30. Young PM, Price R, Tobyn MJ, Buttrum M, Dey F. 2003. Effect of humidity on aerosolization of micronized drugs. Drug Dev Ind Pharm 29:959-966.
31. Bell JH, Hartley PS, Cox JS. 1971. Dry powder aerosols. I. A new powder inhalation device. J Pharm Sci 60:1559-1564.
32. Zeng XM, Pandhal KH, Martin GP. 2000. The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols. Int J Pharm 197:41-52.
33. Young PM, Edge S, Traini D, Jones MD, Price R, El-Sabawi D, Urry C, Smith C. 2005. The influence of dose on the performance of dry powder inhalation systems. Int J Pharm 296:26-33.